| Stage | CRAI | % of rev | EXPO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $186M | 100.00% | $172M | 100.00% | CRAI ×1.08 |
| Gross profit | $54M | 29.28% | $71M | 41.40% | EXPO +12.1pp |
| Operating income | $17M | 9.26% | $28M | 16.33% | EXPO +7.1pp |
| Pre-tax income | $16M | 8.73% | $41M | 23.75% | EXPO +15.0pp |
| Net income | $11M | 6.17% | $29M | 17.13% | EXPO +11.0pp |
| Stage | CRAI | EXPO | Gap · A − B |
|---|---|---|---|
| Revenue | $186M100.00% | $172M100.00% | CRAI ×1.08 |
| Gross profit | 29.28%$54M | 41.40%$71M | EXPO +12.1pp |
| Operating income | 9.26%$17M | 16.33%$28M | EXPO +7.1pp |
| Pre-tax income | 8.73%$16M | 23.75%$41M | EXPO +15.0pp |
| Net income |
| 6.17%$11M |
| 17.13%$29M |
| EXPO +11.0pp |
None
No disclosed counterparties: CRAI.